Gram-positive bacterial cell membrane and cytoplasmic components

Cutibacterium acnes and other Gram-positive bacterial cell membranes and cytoplasmic components represent a broad set of therapeutic targets for treating skin infections and acne vulgaris. The cell membrane provides structural integrity and regulates the transport of nutrients and waste, while cytoplasmic components include the ribosomes and enzymes essential for protein synthesis and metabolism (PubMed: PMC3535073). Drugs targeting these structures include oxidizing agents like benzoyl peroxide, which non-specifically disrupts membranes and proteins, and antibiotics like clindamycin or tetracyclines, which specifically inhibit the bacterial ribosome (StatPearls: Benzoyl Peroxide). Because C. acnes is a commensal organism, targeting these components aims to reduce bacterial overgrowth and the subsequent inflammatory response triggered by bacterial metabolites. However, the broad-spectrum nature of many of these treatments can lead to antibiotic resistance and the disruption of the healthy skin flora (NCBI: Antibiotic Classification). These targets are central to dermatological pharmacology, balancing the need for bacterial suppression with the maintenance of skin barrier function.

Other names

Cutibacterium acnes cell membraneBacterial cytoplasmic componentsPropionibacterium acnes cell wallGram-positive bacterial envelope

Antimicrobial agents targeting these components work through various mechanisms: benzoyl peroxide releases free radical oxygen to oxidize bacterial proteins and membranes (StatPearls, 2023); macrolides and lincosamides bind to the 50S ribosomal subunit to inhibit protein synthesis (NCBI, 2022); and tetracyclines bind to the 30S ribosomal subunit to prevent the attachment of aminoacyl-tRNA (PubMed, 2021).